ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,535, issued on Aug. 12, was assigned to CHINA PHARMACEUTICAL UNIVERSITY (Jiangsu, China).
"Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor" was invented by Qidong You (Suzhou, China), Zhengyu Jiang (Suzhou, China), Mengchen Lu (Suzhou, China), Xian Zhang (Suzhou, China), Jing Zhao (Suzhou, China), Xiaoke Guo (Suzhou, China), Xiaoli Xu (Suzhou, China) and Lei Wang (Suzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a hydrogen peroxide-responsive Keap1-Nrf2 PPI inhibitor prodrug, and a preparation method therefor. The hydrogen peroxide-responsive Keap1-Nrf2 PPI...